Botanical species · safety record

Ceiba pentandra

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 adverse-effect records for Ceiba pentandra. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ceiba pentandra (L.) Gaertn.

4Constituent measurements
2Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Isoflavones1
  • Malvalic acid1
  • Sterculic acid1
  • Tannins1

Plant parts

  • Seed4
  • Bark1
  • Leaves1

Preparations

  • Drying (dehydration)2
  • Solvent extraction2

Effect types

  • Hepatotoxicity1
  • Systemic1

Target tissues

  • Liver1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
IsoflavonesBarkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Malvalic acidSeedDrying (dehydration)7.5 PercentGaschromatography (GC)No resolvable identifier
Sterculic acidSeedDrying (dehydration)3.1 PercentGaschromatography (GC)No resolvable identifier
TanninsLeavesSolvent extraction108 Gram/kilogramUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverSeedRat (as animal)Short-term toxicityNo resolvable identifier
SystemicSeedGallus gallus (chicken) (as animal)Short-term toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Mondal, B. Physicochemical characteristics, fatty acid composition and nutritional evaluation of four minor oils. Journal of microbiology, biotechnology and food sciences, 2015, p. 301-305.
  2. Kongmanila, D., Ledin, I. Chemical composition of some tropical foliage species and their intake and digestibility by goats. Asian-australasian journal of animal sciences, 2009, vol. 22, no. 6, p. 803-811.
  3. Kadirvel, R., Natanam, R., Udayasurian, K. Use of kapok as a poultry feed. Poultry Science, 1986, p. 2363-2365.
  4. Ueda, H., Kaneda, N., Kawanishi, K., Alves, SM., Moriyasu, M. A new isoflavone glycoside from Ceiba pentandra (L.) Gaertner. CHEMICAL & PHARMACEUTICAL BULLETIN, 2002, vol. 50, no. 3, p. 403-404. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue